Min Deng

10PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSynthetic biologyParticle physicsEnergy generation, conversion and storage (excl. chemical and electrical)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 30, 2026
Ursodeoxycholic acid enhances cancer radioimmunotherapy by releasing a human-biased FXR-TRIM22-STAT1 immune brake.

|Feb 24, 2026
Combination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDAC.

Xin Xu, Xin Chen, Rongli Xu

|Jan 08, 2026
Redox-driven ADAR1 activation promotes Okazaki fragment maturation and DNA replication integrity.

Bin Chen, Guangchao Sun, Jake A Kloeber

|Dec 12, 2025
USP29 and SMURF1 orchestrate FSP1-mediated ferroptosis suppression to facilitate chemoresistance in gastric cancer.

Zheming Wu, Xinyi Tu, Shouhai Zhu

|May 10, 2023
A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors.

Chao Zhang, Qiang Guo, Lifeng Chen

|Nov 18, 2021
RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination.

Qian Zhu, Jinzhou Huang, Hongyang Huang

Pageof 2

Frequent Collaborators

10 joint publications

Zhenkun Lou

5 joint publications

Somaira Nowsheen

4 joint publications

Jake Kloeber

2 joint publications

Xin Xu